A global biopharmaceutical company
Planned finish on a drug program pulled 6 to 7 months earlier.
Two focused people did what usually took six, and faster.
6-7 monthspulled from a program's planned finish
2 for 6focused people boosted productivity and speed over the usual ways of working
3 daysfor a review that used to take 10
The situation
Six drug development projects across four therapeutic areas, in a pilot to see whether clinical work could move faster.
What changed
One schedule per program, focused people on the tasks that determined speed, and fast turnarounds on the reviews holding up the work.
The result
- Program leadership credits at least half of the 6-to-7-month gain to the new way of running the work.
- Two people working with focus completed work that usually took six, and completed it faster.
- An internal review approval came back in 3 days instead of 10.
- A clinical study finished on time to an aggressive timeline.
- A clear view of resource constraints enabled major spending and staffing commitments to be pushed out until they were actually needed (at least 1 year).